BNT162b2疫苗对组粒和δ变异导致的严重后果的免疫损害和持久性

{"title":"BNT162b2疫苗对组粒和δ变异导致的严重后果的免疫损害和持久性","authors":"S. Tartof, J. Slezak, L. Puzniak, V. Hong, Fagen Xie, B. Ackerson, S. Valluri, L. Jodar, J. McLaughlin","doi":"10.1016/S2213-2600(22)00170-9","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":326030,"journal":{"name":"The Lancet. Respiratory medicine","volume":"16 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"16","resultStr":"{\"title\":\"Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variants\",\"authors\":\"S. Tartof, J. Slezak, L. Puzniak, V. Hong, Fagen Xie, B. Ackerson, S. Valluri, L. Jodar, J. McLaughlin\",\"doi\":\"10.1016/S2213-2600(22)00170-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":326030,\"journal\":{\"name\":\"The Lancet. Respiratory medicine\",\"volume\":\"16 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"16\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet. Respiratory medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/S2213-2600(22)00170-9\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet. Respiratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/S2213-2600(22)00170-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}